VISUAL IMPAIRMENT

Adverse reaction reported in 30,737 FDA reports across 26 drugs.

30,737

Total Reports

Drugs Involved

Insulin Glargine

Most Reported Drug

Drugs Associated with VISUAL IMPAIRMENT

Drugs where "VISUAL IMPAIRMENT" was reported as an adverse event.

#	Drug	Reports	% of Total
1	Insulin Glargine	8,661	28.2%
2	Insulin Lispro	5,491	17.9%
3	Fingolimod	2,597	8.4%
4	Aflibercept	2,088	6.8%
5	Ranibizumab	1,629	5.3%
6	Insulin Human	1,488	4.8%
7	Insulin Aspart	1,331	4.3%
8	Latanoprost	986	3.2%
9	Insulin Detemir	734	2.4%
10	Trametinib	605	2.0%
11	Lifitegrast	572	1.9%
12	Dabrafenib	520	1.7%
13	Insulin Degludec	484	1.6%
14	Bimatoprost	463	1.5%
15	Crizotinib	404	1.3%
16	Brimonidine	386	1.3%
17	Budesonide, Glycopyrrolate, / Formoterol Fumarate	317	1.0%
18	Cenegermin-Bkbj	279	0.9%
19	Siponimod	269	0.9%
20	Insulin Glulisine	241	0.8%
21	Carboxymethylcellulose	241	0.8%
22	Travoprost	215	0.7%
23	Timolol	203	0.7%
24	Encorafenib	189	0.6%
25	Dorzolamide Hydrochloride / Timolol Maleate	173	0.6%
26	Vigabatrin	171	0.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused visual impairment. Always consult your healthcare provider.